2019 New Mexico Statutes
Chapter 24 - Health and Safety
Article 23 - Administration of Opioid Antagonists
Section 24-23-3 - Opioid treatment center; opioid overdose education; naloxone.
A. As agency funding and agency supplies of naloxone permit, an opioid treatment center agency operating a federally certified program to dispense methadone or other narcotic replacement as part of a detoxification treatment or maintenance treatment shall provide each patient it treats with:
(1) opioid overdose education that:
(a) conforms to department of health or federal substance abuse and mental health services administration guidelines for opioid overdose education;
(b) explains the causes of an opioid overdose;
(c) instructs when and how to administer in accordance with medical best practices: 1) life-saving rescue techniques; and 2) an opioid antagonist; and
(d) explains how to contact appropriate emergency medical services;
(2) two doses of naloxone in either a generic form or in a form approved by the federal food and drug administration; and
(3) a prescription for naloxone.
B. As used in this section, "naloxone" means naloxone hydrochloride, which is an opioid antagonist for the treatment of opioid overdose.
History: Laws 2017, ch. 59, § 1.
ANNOTATIONSEffective dates. — Laws 2017, ch. 59 contained no effective date provision, but, pursuant to N.M. Const., art. IV, § 23, was effective June 16, 2017, 90 days after the adjournment of the legislature.
